About the CRISPR and Gene Editing in Cancer Therapy Session
CRISPR and gene editing technologies have revolutionized the field of cancer therapy by providing the ability to precisely alter the genetic makeup of cancer cells. CRISPR, a tool that enables targeted gene editing, allows researchers to deactivate cancer-causing genes or correct genetic mutations that contribute to tumor growth. This technology holds the potential to not only treat cancer by directly targeting tumor cells but also to enhance the immune system’s ability to recognize and destroy cancer cells. Additionally, CRISPR could be used to modify immune cells, such as T cells, to improve their efficacy in fighting cancer. While still in the early stages, CRISPR-based therapies have shown promise in preclinical studies and clinical trials, offering new hope for more effective and personalized cancer treatments.
Topics Covered in CRISPR and Gene Editing in Cancer Therapy
Functional CRISPR Screens
Base & Prime Editing
Gene-Edited T Cells
Oncogene Knockout
Off-Target Effects
Editor Delivery Vehicles
Related Scientific Sessions at CIOC 2027
Why Attend the CRISPR and Gene Editing in Cancer Therapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original CRISPR and Gene Editing in Cancer Therapy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping CRISPR and Gene Editing in Cancer Therapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the CRISPR and Gene Editing in Cancer Therapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
CRISPR and Gene Editing in Cancer Therapy Conference 2027 — FAQs
What is the CRISPR and Gene Editing in Cancer Therapy track at CIOC 2027?
The CRISPR and Gene Editing in Cancer Therapy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in CRISPR and Gene Editing in Cancer Therapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the CRISPR and Gene Editing in Cancer Therapy sessions?
Cancer researchers and clinicians, educators and students with an interest in CRISPR and Gene Editing in Cancer Therapy are all welcome — whether presenting or attending.
Can I present my research in the CRISPR and Gene Editing in Cancer Therapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for CRISPR and Gene Editing in Cancer Therapy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the CRISPR and Gene Editing in Cancer Therapy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.